| All SSc patients | Limited or diffuse SSc | Undifferentiated SSc |
---|---|---|---|
Number of patients | 41 | 31 | 10 |
Female | 88% (36/41) | 90 % (28/31) | 80% (8/10) |
Mean age (min-max) | 58 (23-84) | 59.6 (33-84) | 54 (23-79) |
Mean duration of SSc, years (min-max) | 9 (2-40) | 10.4 (2-40) | 5 (2-13) |
Mean duration of Raynaud, years (min-max) | 12 (2-40) | 12.4 (2-40) | 7.5 (2-25) |
Lung symptoms | 41% (17/41) | 48% (15/31) | 20% (2/10) |
Skin involvement | 85% (35/41) | 94% (29/31) | 60% (6/10) |
Raynaud phenomenon | 100% (41/41) | 100% (31/31) | 100% (10/10) |
Pitting scars | 29% (12/41) | 35% (11/31) | 10% (1/10) |
Digital ulcers | 15% (6/41) | 19% (6/31) | 0% |
GI-tract involvement | 37% (15/41) | 45% (14/31) | 10% (1/10) |
Arthralgia/arthritis | 15% (6/41) | 19% (6/31) | 0% |
PAH | 12% (5/41) | 13% (4/31) | 10% (1/10) |
Renal crisis | 2% (1/41) | 3% (1/31) | 0% |
Calcinosis cutis | 22% (9/41) | 29% (9/31) | 0% |
Karnofski index (min-max) | 77% (50-100%) | 70% (50-100%) | 84% (70-100%) |
Rodnan score (min-max) | 6.7 (1-31) | 8.0 (1-31) | 2.8 (1-6) |
SF-36 scores mean (min-max) | Â | Â | Â |
Physical function | 65.8 (5.6-100.0) | 61.1 (5.6-100.0) | 71.0 (33.3-100.0) |
Physical role | 66.2 (0.0-100.0) | 70.2 (0.0-100.0) | 54.6 (0.0-100.0) |
Bodily pain | 59.0 (22.0-100.0) | 58.7 (22.0-100.0) | 60.1 (25.0-100.0) |
General health | 53.6 (15.0-97.0) | 51.5 (15.0-92.0) | 59.4 (18.8-100.0) |
Vitality | 54.1 (5.0-95.0) | 53.3 (5.0-95.0) | 56.5 (35.0-75.0) |
Social function | 76.6 (0.0-100.0) | 75.9 (0.0-100.0) | 78.8 (50.0-100.0) |
Emotional role | 73.1 (0.0-100.0) | 76.5 (0.0-100.0) | 63.0 (0.0-100.0) |
Mental health | 72.0 (28.0-100.0) | 70.7 (28.0-100.0) | 75.8 (52.0-88.0) |